NASDAQ:APRE

Aprea Therapeutics Stock Predictions

etoro logo Buy APRE
*Your capital is at risk
$0.762
-0.0022 (-0.288%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

APRE Prediction Chart

APRE Predictions History

Latest community submissions for APRE.
Predictor Target Session Target Price Result Direction Accuracy Score
May 11, 2026 $0.94 -4.00% $0.93 V 98.88% 2
May 11, 2026 $0.95 -3.46% $0.93 V 98.31% 1
May 11, 2026 $0.96 -2.16% $0.93 V 96.95% 1
May 11, 2026 Bearish $0.93 V 1
May 11, 2026 Bullish $0.93 X 0
May 7, 2026 $0.86 +2.68% $0.88 V 97.18% 1
May 7, 2026 $0.80 -3.58% $0.88 X 91.25% 0
May 7, 2026 $0.81 -2.24% $0.88 X 92.52% 0
May 7, 2026 Bullish $0.88 V 1
May 4, 2026 $0.84 +2.94% $0.84 V 99.85% 6
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for APRE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT APREA THERAPEUTICS INC.
Aprea Therapeutics
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE